Solvonis Therapeutics plc (LON:SVNS)
London · Delayed Price · Currency is GBP · Price in GBX 0.1150
-0.0050 (-4.17%)
Sep 4, 2026, 4:07 PM GMT
Solvonis Therapeutics Market Cap
Solvonis Therapeutics has a market cap or net worth of 7.83 million as of September 4, 2026. Its market cap has decreased by -54.73% in one year.
Market Cap
7.83M
Enterprise Value
6.18M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.12
ChartMarket Cap Chart
Since January 6, 2022, Solvonis Therapeutics's market cap has decreased from 23.03M to 7.83M, a decrease of -66.01%. That is a compound annual growth rate of -20.66%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 7.83M | -62.90% |
| Dec 31, 2025 | 21.10M | 348.30% |
| Dec 31, 2024 | 4.71M | 686.33% |
| Dec 29, 2023 | 598.56K | -95.86% |
| Dec 30, 2022 | 14.47M | -37.18% |
| Jan 6, 2022 | 23.03M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| IXICO | 16.35M |
| Fusion Antibodies | 14.71M |
| Genflow Biosciences | 12.18M |
| Aptamer Group | 12.09M |
| Cizzle Biotechnology Holdings | 6.37M |
| CRISM Therapeutics | 6.10M |
| OptiBiotix Health | 5.94M |
| Thalia Therapeutics | 5.20M |